Diabetes Mellitus Type 2: “A latent danger”

Abstract

Type 2 diabetes mellitus is a multifactorial and chronic disease that requires comprehensive treatment throughout the patient's life and with the need for constant adjustments according to the specific requirements of each patient. It has been identified that weight loss in diabetic patients can delay the progression of the disease and even delay or prevent its onset. In addition to being a beneficial factor in the treatment goals of diabetic patients, weight loss can achieve clinically significant changes in total serum glucose, glycated hemoglobin (HbA1C), and triglyceride concentrations. Currently, evidence-based recommendations are aimed at pharmacological, surgical intervention and lifestyle changes in the management of obesity as part of the comprehensive treatment of patients with type 2 diabetes mellitus. Traditional pharmacological treatments against diabetes mellitus type 2 may further increase weight and this may diminish the benefits of adequate glycemic control. It is important to identify the influence of each group of drugs on weight.